27.12.2012 Views

section 1 - World Intellectual Property Organization

section 1 - World Intellectual Property Organization

section 1 - World Intellectual Property Organization

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

44/2002<br />

31 Oct/oct 2002 PCT Gazette - Section I - Gazette du PCT 21621<br />

(25) fr (26) fr<br />

(30) 01/05554 25 Apr/avr 2001 FR<br />

(25.04.2001)<br />

(43) 31 Oct/oct 2002 (31.10.2002)<br />

(54) MEDICINAL TABLET WITH PRO-<br />

LONGED RELEASE OF THE ACTIVE<br />

PRINCIPLE<br />

PASTILLE MEDICAMENTEUSE A LI-<br />

BERATION LENTE DU PRINCIPE AC-<br />

TIF<br />

(71) PIERRE FABRE MEDICAMENT<br />

[FR/FR]; 45, place Abel-Gance, F-92100<br />

Boulogne (FR).<br />

(for all designated States except / pour tous<br />

les États désignés sauf US)<br />

(72, 75) DUPINAY, Pierre [—/FR];LeVillage,<br />

F-31460 Toutens (FR). TORRES, Robert<br />

[—/FR]; 19, rue Docteur Arrazat, F-31520<br />

Ramonville Saint Agne (FR).<br />

(74) MARTIN, Jean-Jacques et al. / etc.; Cabinet<br />

Regimbeau, 20, rue de Chazelles, F-75847<br />

Paris Cedex 17 (FR).<br />

(81) BR CA CN JP MX US.<br />

(84) EP (AT BE CH CY DE DK ES FI FR GB GR<br />

IE IT LU MC NL PT SE TR).<br />

Published / Publiée : (c)<br />

(51) 7 A61K 9/22, 9/32, 9/36, 9/58, 9/62<br />

(11) WO 02/085335 (13) A1<br />

(21) PCT/US02/12140<br />

(22) 18 Apr/avr 2002 (18.04.2002)<br />

(25) en (26) en<br />

(30) 60/284,463 18 Apr/avr 2001 US<br />

(18.04.2001)<br />

(43) 31 Oct/oct 2002 (31.10.2002)<br />

(54) A NOVEL COATING FOR A SUS-<br />

TAINED RELEASE PHARMACEUTI-<br />

CAL COMPOSITION<br />

NOUVEL ENROBAGE DE COMPOSI-<br />

TION PHARMACEUTIQUE A LIBERA-<br />

TION LENTE<br />

(71) NOSTRUM PHARMACEUTICALS INC.<br />

[US/US]; 203 Somerset Court, Princeton, NJ<br />

08540 (US).<br />

(72) MULYE, Nirmal; 203 Somerset Court,<br />

Princeton, NJ 08540 (US).<br />

(74) GROLZ, Edward, W. et al. / etc.; Scully,<br />

Scott, Murphy & Presser, 400 Garden City<br />

Plaza, Garden City, NY 11530 (US).<br />

(81) AE AG AL AM AT AU AZ BA BB BG BR<br />

BY BZ CA CH CN CO CR CU CZ DE DK<br />

DM DZ EC EE ES FI GB GD GE GH GM<br />

HR HU ID IL IN IS JP KE KG KP KR KZ<br />

LC LK LR LS LT LU LV MA MD MG MK<br />

MN MW MX MZ NO NZ OM PH PL PT RO<br />

RU SD SE SG SI SK SL TJ TM TN TR TT<br />

TZ UA UG UZ VN YU ZA ZM ZW.<br />

(84)AP(GHGMKELSMWMZSDSLSZTZ<br />

UG ZM ZW); EA (AM AZ BY KG KZ MD<br />

RU TJ TM); EP (AT BE CH CY DE DK ES<br />

FI FR GB GR IE IT LU MC NL PT SE TR);<br />

OA(BFBJCFCGCICMGAGNGQGW<br />

ML MR NE SN TD TG).<br />

Published / Publiée : (c)<br />

(51) 7 A61K 9/46<br />

(11) WO 02/085336 (13) A1<br />

(21) PCT/FR02/01321<br />

(22) 17 Apr/avr 2002 (17.04.2002)<br />

(25) fr (26) fr<br />

(30) 01/05389 20 Apr/avr 2001 FR<br />

(20.04.2001)<br />

(43) 31 Oct/oct 2002 (31.10.2002)<br />

(54) ORODISPERSIBLE EFFERVESCENT<br />

TABLETS<br />

COMPRIMES EFFERVESCENTS ORO-<br />

DISPERSIBLES<br />

(71) ETHYPHARM [FR/FR]; 21, rue Saint<br />

Matthieu, F-78550 Houdan (FR).<br />

(for all designated States except / pour tous<br />

les États désignés sauf US)<br />

(72, 75) DELMAS, Pascal [FR/CA]; 97 rue Mc-<br />

Culloch, Outremont, Quebec H2V 3L8 (CA).<br />

ZUCCARELLI, Jean-Marc [FR/FR]; 126<br />

chemin de la Parouquine, F-06600 Antibes<br />

(FR). MALLARD, Claire [FR/FR]; Rue des<br />

Petits Ponts, F-06250 Mougins le Haut (FR).<br />

MCGINITY, James, W. [US/US]; 4209<br />

Dunning Lane, Austin, TX 78746 (US).<br />

(74) TOUATI, Catherine et al. / etc.; Cabinet<br />

Plasseraud, 84, rue d’Amsterdam, F-75440<br />

Paris Cedex 09 (FR).<br />

(81) AE AG AL AM AT AU AZ BA BB BG BR<br />

BY BZ CA CH CN CO CR CU CZ DE DK<br />

DM DZ EC EE ES FI GB GD GE GH GM<br />

HR HU ID IL IN IS JP KE KG KP KR KZ<br />

LC LK LR LS LT LU LV MA MD MG MK<br />

MN MW MX MZ NO NZ OM PH PL PT RO<br />

RU SD SE SG SI SK SL TJ TM TN TR TT<br />

TZ UA UG US UZ VN YU ZA ZM ZW.<br />

(84)AP(GHGMKELSMWMZSDSLSZTZ<br />

UG ZM ZW); EA (AM AZ BY KG KZ MD<br />

RU TJ TM); EP (AT BE CH CY DE DK ES<br />

FI FR GB GR IE IT LU MC NL PT SE TR);<br />

OA(BFBJCFCGCICMGAGNGQGW<br />

ML MR NE SN TD TG).<br />

Published / Publiée : (c)<br />

Declaration / Déclaration :<br />

(u) for / pour US only / seulement<br />

(51) 7 A61K 9/51<br />

(11) WO 02/085337 (13) A1<br />

(21) PCT/CA02/00542<br />

(22) 22 Apr/avr 2002 (22.04.2002)<br />

(25) en (26) en<br />

(30) 60/284,884 20 Apr/avr 2001 US<br />

(20.04.2001)<br />

(43) 31 Oct/oct 2002 (31.10.2002)<br />

(54) MICELLAR DRUG DELIVERY SYS-<br />

TEMS FOR HYDROPHOBIC DRUGS<br />

SYSTEMES D’ADMINISTRATION DE<br />

MEDICAMENT MICELLAIRE POUR<br />

MEDICAMENTS HYDROPHOBES<br />

(71) THE UNIVERSITY OF BRITISH CO-<br />

LUMBIA [CA/CA]; University-Industry<br />

Liaison Office, IRC Room 331, 2194 Health<br />

Sciences Mall, Vancouver, British Columbia<br />

V6T 1Z3 (CA).<br />

(for all designated States except / pour tous<br />

les États désignés sauf US)<br />

(72, 75) JACKSON, John, K. [CA/CA]; 540<br />

West 29th Avenue, Vancouver, British Columbia<br />

V5Z 2H7 (CA). ZASTRE, Jason<br />

[CA/CA]; 6950 Fremlin Street, Vancouver,<br />

British Columbia V6P 3W4 (CA). BURT,<br />

Helen, M. [CA/CA]; 3182West 28th Avenue,<br />

Vancouver, BritishColumbia V6L 1X5 (CA).<br />

(74) ROBINSON, J., Christopher et al. / etc.;<br />

Smart & Biggar, Suite 2200, 650 West Georgia<br />

Street, Box 11560 Vancouver Centre, Vancouver,<br />

British Columbia V6B 4N8 (CA).<br />

(81) AE AG AL AM AT AU AZ BA BB BG BR<br />

BY BZ CA CH CN CO CR CU CZ DE DK<br />

DM DZ EC EE ES FI GB GD GE GH GM<br />

HR HU ID IL IN IS JP KE KG KP KR KZ<br />

LC LK LR LS LT LU LV MA MD MG MK<br />

MN MW MX MZ NO NZ OM PH PL PT RO<br />

RU SD SE SG SI SK SL TJ TM TN TR TT<br />

TZ UA UG US UZ VN YU ZA ZM ZW.<br />

(84)AP(GHGMKELSMWMZSDSLSZTZ<br />

UG ZM ZW); EA (AM AZ BY KG KZ MD<br />

RUTJTM);EP(ATBECHCYDEDKES<br />

FI FR GB GR IE IT LU MC NL PT SE TR);<br />

OA(BFBJCFCGCICMGAGNGQGW<br />

ML MR NE SN TD TG).<br />

Published / Publiée : (c)<br />

(51) 7 A61K 9/72, 31/46<br />

(11) WO 02/085338 (13) A2<br />

(21) PCT/CA02/00450<br />

(22) 3 Apr/avr 2002 (03.04.2002)<br />

(25) en (26) en<br />

(30) 09/841,181 23 Apr/avr 2001<br />

(23.04.2001)<br />

US<br />

(43) 31 Oct/oct 2002 (31.10.2002)<br />

(54) IPRATROPIUM FORMULATION FOR<br />

PULMONARY INHALATION<br />

FORMULATION D’IPRATROPIUM<br />

POUR INHALATION PULMONAIRE<br />

(71) PHARMASCIENCE INC. [CA/CA]; 6111<br />

Royalmount Avenue, Suite 100, Montréal,<br />

Québec H4P 2T4 (CA).<br />

(72) WULFFHART,Harold;85SkymarkDrive,<br />

Classic, Suite 2006, North York, Toronto, Ontario<br />

M2H 3P2 (CA). AYOUB, Khaldoun;<br />

32 Tomlin Circle, Richmond Hill, Ontario<br />

L4C 7T3 (CA). LOGIUDICE, Rosemary;<br />

182 Misty Meadow Drive, Woodbridge, Ontario<br />

L4L 3V7 (CA). PISKORZ, Hanna;30<br />

Vitlor Drive, Richmond Hill, Ontario L4E<br />

3W3 (CA).<br />

(74) OGILVY RENAULT et al. / etc.; Suite<br />

1600, 1981 McGill College Avenue, Montreal,<br />

Québec H3A 2Y3 (CA).<br />

(81) AU CA JP.<br />

(84)EP(ATBECHCYDEDKESFIFRGBGR<br />

IE IT LU MC NL PT SE TR).<br />

(51) 7 A61K 9/72<br />

(11) WO 02/085339 (13) A1<br />

(21) PCT/US02/07550<br />

(22) 13 Mar/mar 2002 (13.03.2002)<br />

(25) en (26) en<br />

(30) 09/834,158 12 Apr/avr 2001<br />

(12.04.2001)<br />

US<br />

(43) 31 Oct/oct 2002 (31.10.2002)<br />

(54) PHASE CHANGE THERMAL INTER-<br />

FACE COMPOSITION HAVING IN-<br />

DUCED BONDING PROPERTY<br />

COMPOSITION D’INTERFACE THER-<br />

MIQUE A CHANGEMENT DE PHASE<br />

PRESENTANT UNE PROPRIETE DE<br />

LIAISON INDUITE

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!